Molecular and clinical spectrum of primary hyperparathyroidism
S Jha, WF Simonds - Endocrine Reviews, 2023 - academic.oup.com
Recent data suggest an increase in the overall incidence of parathyroid disorders, with
primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is …
primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is …
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
C Belhadj Slimane, I Oueslati… - Clinical Medicine …, 2023 - journals.sagepub.com
Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de
novo psychiatric symptoms during dopamine agonist therapy is low. Herein, we report the …
novo psychiatric symptoms during dopamine agonist therapy is low. Herein, we report the …
[HTML][HTML] Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1
ISM Miranda, LP Valadares, GB Barra… - Frontiers in …, 2023 - frontiersin.org
Objective Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome
characterized by its clinical variability and complexity in diagnosis and treatment. We …
characterized by its clinical variability and complexity in diagnosis and treatment. We …
[HTML][HTML] Multiple endocrine neoplasia type 1 in patients with gastroenteropancreatic neuroendocrine tumors: An opportunity for early diagnosis and appropriate …
E Pereira Brabo… - Molecular and …, 2020 - spandidos-publications.com
Gastroenteropancreatic neuroendocrine tumors (GEPNET) are rare tumors that may be
sporadic or develop as part of multiple endocrine neoplasia type 1 syndrome (MEN1). The …
sporadic or develop as part of multiple endocrine neoplasia type 1 syndrome (MEN1). The …